@article{87db0e2bdec14251b309c75e69e18287,
title = "Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer",
author = "Ibrahim, \{Nuhad K.\} and Brian Samuels and Ray Page and Dinesh Doval and Patel, \{Kirtikumar M.\} and S.C. Rao and Nair, \{Madhavan Krishnan\} and Paul Bhar and Neil Desai and Hortobagyi, \{Gabriel N.\}",
note = "Purpose ABI-007 is a novel nanoparticle, albumin-bound paclitaxel that is free of solvents. This multicenter phase II study was designed to evaluate the efficacy and safety of ABI-007 for the treatment of metastatic breast cancer (MBC). Patients and Methods Sixty-three women with histologically confirmed and measurable MBC received 300 mg/m2 ABI-007 by intravenous infusion over 30 minutes every 3 weeks without premedication.",
year = "2005",
month = sep,
day = "1",
doi = "10.1200/JCO.2005.11.013",
language = "American English",
volume = "23",
journal = "Journal of Clinical Oncology",
number = "25",
}